About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

JDQ443 for KRAS G12C NSCLC Brain Metastases | Clinical Trials | Clareo Health

WITHDRAWNPhase 2

JDQ443 for KRAS G12C NSCLC Brain Metastases

A Phase II Study evaluaTing intRacranial effIcacy of JDQ443 in patiEnts With KRAS G12C+ NSCLC and bRain Metastases

NCT05999357•Maastricht University Medical Center

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Non Small Cell Lung Cancer MetastaticBrain Metastases, AdultKRAS G12C

Interventions

JDQ443

Key Dates

Start Date

April 15, 2024

Primary Completion Date

August 1, 2027

Completion Date

August 1, 2028

Last Updated

May 29, 2024

Related Studies

RECRUITINGPhase 2

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

NCT07130786

SeizuresPrimary Motor Cortex+3 more

RECRUITINGPhase 1/2

Effect of Azeliragon Combined With Stereotactic Radiation Therapy in Patients With Brain Metastases

NCT05789589

CancerMetastasis+3 more

RECRUITINGPhase 1

Open-label Study of BBO-8520 in Adult Subjects With KRASG12C Non-small Cell Lung Cancer

NCT06343402

Non-small Cell Lung CancerMetastatic Non-Small Cell Lung Cancer+4 more

RECRUITINGPhase 2

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

NCT05419076

Lung CancerLung Cancer Metastatic+4 more

Multi-disciplinary Care for Brain Metastases

NCT06280300

Brain Metastases, Adult

RECRUITINGPhase 1/2

Study of Stereotactic Radiosurgery With Olaparib Followed by Durvalumab and Physician's Choice Systemic Therapy in Subjects With Breast Cancer Brain Metastases

NCT04711824

Breast CancerBrain Metastases, Adult

View all related studies

Sponsors

Lead Sponsor

Maastricht University Medical Center

Collaborators

Novartis

Detailed Description

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 29, 2024Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions